{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-131872","form_type":"8-K","ticker":"ASMB","cik":"0001426800","company_name":"ASSEMBLY BIOSCIENCES, INC.","filed_at":"2026-03-30T23:59:59+00:00","discovered_at":"2026-05-14T18:02:35.057442+00:00","generated_at":"2026-05-15T08:21:26.507997+00:00","sec_items":["5.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"Assembly Biosciences adopts 2026 bonus plan; raises CEO bonus target to 65%","bullets":["Compensation Committee approved 2026 Corporate Bonus Plan effective Jan 1, 2026 with corporate and individual performance objectives.","CEO Jason Okazaki's bonus target increased from 60% to 65% of base salary via Amendment No. 1 to employment agreement.","Bonus targets range: CEO up to 75%, other executives 30-55%, non-executives up to 28% of base salary.","Bonuses range from 0 to 1.5 times target; payment expected in Q1 of following year, no later than March 15."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-131872","json":"https://secwatch.observer/filing/0001193125-26-131872.json","markdown":"https://secwatch.observer/filing/0001193125-26-131872.md","text":"https://secwatch.observer/filing/0001193125-26-131872.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1426800/000119312526131872/0001193125-26-131872-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1426800/000119312526131872/asmb-20260324.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T08:21:26.507997+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}